Zacks Industry Outlook Applied Materials, Lam Research and FormFactor

The semiconductor industry has gained 42.9% over the past year, outperforming the broader technology sector (+27.2%) and the S&P 500 (+16%), as AI demand supports advanced logic, memory and packaging investment. Industry earnings estimates for the current year rose 152.6% since Jan. 31, 2026; the article highlights FormFactor, Applied Materials and Lam Research, while noting supply constraints, higher manufacturing costs and tariffs as risks. Applied Materials expects advanced-packaging revenue to grow more than 70% in calendar 2026, and Lam Research expects its advanced-packaging business to grow more than 70% year over year.

Analysis

The key distinction is between durable process-intensity gains and a near-term AI capex cycle. More complex HBM, chiplet and 3D structures can increase equipment and test content per wafer, even if total wafer starts disappoint. But packaging capacity and HBM availability are bottlenecks: they can delay customer ramps and tool acceptance, so demand claims do not translate automatically into recognized revenue. This favors diversified process exposure (AMAT) over a thesis reliant on one adoption curve; LRCX also carries greater sensitivity to NAND investment timing. FORM’s probe-card opportunity is strategically credible, but the article’s own cited estimate revisions are slightly negative, and the claimed acceleration is mainly a 2027 setup—not evidence of imminent earnings conversion.

Near term, the group’s strong run raises the bar for incremental positive news. The industry multiple cited by Zacks is not enough to establish cheapness: verify its constituents, earnings basis and comparability before relying on it. The promotional source and rank-based framing are not substitutes for order, revenue or cash-flow evidence. Over 1–3 months, watch equipment orders, customer capex guidance, HBM/packaging capacity and estimate revisions. Over 6–18 months, sustained AI infrastructure spending could broaden demand, while export restrictions or tariffs may raise costs, redirect supply chains and defer China-related demand; company-specific exposure needs verification. A capex pause, delayed packaging ramps or worsening estimates would invalidate the bullish setup.

Key Decisions for Investors

• Avoid chasing the semiconductor-equipment rally on this article alone. Consider adding AMAT or LRCX only on a pullback or after order/guidance confirmation; size as a cyclical capex exposure, not a pure secular-growth holding.
• Prefer AMAT over FORM for a relative long bias pending evidence that FORM’s test demand is converting into improving estimates. Do not short FORM solely on the small estimate downgrade: HBM4 qualification and probe-card adoption could produce upside, but timing is uncertain.
• Treat LRCX as a higher-beta expression: monitor NAND customer spending alongside advanced-packaging growth. Reduce exposure if NAND investment weakens or management commentary indicates delayed tool acceptance.
• Before acting, verify company-level China revenue/export exposure, order-to-revenue conversion, advanced-packaging capacity constraints and estimate revisions. Falsify the thesis on broad capex guidance cuts, repeated shipment/acceptance delays, or estimates rolling over across the group.